Codexis, Inc. Dividend History (CDXS)
Codexis, Inc. does not pay dividends currently 😔
They might in the future, check back soon!
About Codexis, Inc.
Codexis, Inc. is a biotechnology company that specializes in the development of proteins for a variety of applications through its proprietary enzyme engineering technology. Founded in 2002 by Alejandro Zaffaroni, the company is headquartered in Redwood City, California. Codexis focuses on enhancing and creating enzymes for use in pharmaceuticals, food, and other industrial applications, aiming to improve efficiency, cost-effectiveness, and sustainability. Known for its innovative approach, Codexis harnesses the power of protein engineering to optimize processes and create high-performing biocatalysts. As of recent reports, the company has seen a revenue of around $100 million, demonstrating its growing influence and success in the biotech industry. Codexis continues to expand its market presence through partnerships and collaborations, pushing the boundaries of biotechnology to solve complex real-world problems.
Apple Inc.
Microsoft Corporation
Johnson & Johnson
Procter & Gamble Co.
Coca-Cola Co.
PepsiCo, Inc.
Exxon Mobil Corporation
Verizon Communications Inc.
AT&T Inc.
Chevron CorporationThe global artificial sweeteners market is expected to grow at a CAGR of around 4% from 2024 to 2030, driven by the increasing demand for low-calorie foods due to the rising rates of diabetes, hypertension, and obesity, as well as ongoing research and development efforts leading to new product launches.
GlobeNewswire Inc. · Published on Wed Dec 04 2024